12 search results for: IL-4

Airway Remodeling in Type 2 Asthma is Driven by <b>IL-4</b> and IL-13
Pulmonology
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

View more
What role does <b>IL-4</b> and IL-13 have in driving Type 2 inflammatory skin disease (AD, PN, CSU)?
Dermatology
What role does IL-4 and IL-13 have in driving Type 2 inflammatory skin disease (AD, PN, CSU)?
expert video

Dr. Oscar Palomares explains that IL-4 and IL-13 are crucial cytokines in type 2 inflammation, playing both unique and overlapping roles, including T cell expansion and contributing to clinical symptoms in chronic diseases.

View more
<b>IL-4</b> Contributes to Systemic Type 2 Inflammation in AD
Dermatology
IL-4 Contributes to Systemic Type 2 Inflammation in AD
expert video

In this highlight video from the ADVENT AD symposium held at EADV’s 2024 Annual Meeting in Amsterdam, Dr. Stephan Weidinger discusses how IL-4 contributes to systemic type 2 inflammation in AD via several mechanisms, including T cell differentiation, B cell activation and IgE generation, and T regulatory cell inhibition.

View more
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
Gastroenterology
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
expert video

Dr. Jonathan Spergel and Prof. Arjan Bredenoord highlight the importance of different immune cells in type 2 inflammation in EoE.

View more
The Pathophysiology of Prurigo Nodularis
Dermatology
The Pathophysiology of Prurigo Nodularis
videoanimation

An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

View more
KOL Video Interview – Dr Amy Paller
Dermatology
KOL Video Interview – Dr Amy Paller
expert video

In this exclusive video interview, Dr Amy Paller discusses two topics: 1) The importance of CCL17 (TARC) as a biomarker in pediatric patients with AD, and 2) How IL-4 and IL-13 contribute to skin barrier dysfunction in AD.

View more
Learn more about how dysregulated type 2 inflammation contributes to polymorphous lesions and dermal epidermal splitting in bullous pemphigoid
Dermatology
Bullous Pemphigoid (BP) Pathophysiology Infographic
Infographic

A static infographic detailing how autoimmunity and Type 2 inflammation play a critical role in the pathophysiology of Bullous Pemphigoid (BP).

View more
Exploring the Potential Role of Biomarkers in Managing Bullous Pemphigoid
Dermatology
Exploring the Potential Role of Biomarkers in Managing Bullous Pemphigoid
expert video

Dr. Donna Culton discusses biomarkers in bullous pemphigoid and considers their potential clinical use.

View more
Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
Dermatology
Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
expert video

Listen as Dr. Donna Culton discusses the importance of crosstalk between autoantibodies and type 2 inflammation in the development of bullous pemphigoid.

View more
Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
Dermatology
Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
expert video

Join Dr Kwatra as he dives deeper into the mechanism of lesion formation in Prurigo Nodularis and the impact the development of these skin lesions have on patient life.

View more
The Cycle of Inflammation in Adult Asthma
Pulmonology
The Cycle of Inflammation in Adult Asthma
interactivity

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in patients with asthma.

View more
Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
Type 2 Inflammation Contributes to Itch and Fibrois in PN
expert video

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

View more